Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
S Agnihotri, G Zadeh - Neuro-oncology, 2015 - academic.oup.com
A defining hallmark of glioblastoma is altered tumor metabolism. The metabolic shift towards
aerobic glycolysis with reprogramming of mitochondrial oxidative phosphorylation …
aerobic glycolysis with reprogramming of mitochondrial oxidative phosphorylation …
Hypoxia: a key regulator of angiogenesis in cancer
D Liao, RS Johnson - Cancer and Metastasis Reviews, 2007 - Springer
Angiogenesis is an important mediator of tumor progression. As tumors expand, diffusion
distances from the existing vascular supply increases resulting in hypoxia. Sustained …
distances from the existing vascular supply increases resulting in hypoxia. Sustained …
Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways
Exosomes are emerging as important elements that participate in intercellular
communication and tumor microenvironment modulation, but the exact mechanisms by …
communication and tumor microenvironment modulation, but the exact mechanisms by …
Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction
J Xu, J Zhang, Z Zhang, Z Gao, Y Qi, W Qiu, Z Pan… - Cell Death & …, 2021 - nature.com
Exosomes participate in intercellular communication and glioma microenvironment
modulation, but the exact mechanisms by which glioma-derived exosomes (GDEs) promote …
modulation, but the exact mechanisms by which glioma-derived exosomes (GDEs) promote …
'Pseudopalisading'necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
Y Rong, DL Durden, EG Van Meir… - … of Neuropathology & …, 2006 - academic.oup.com
Glioblastoma (GBM) is a highly malignant, rapidly progressive astrocytoma that is
distinguished pathologically from lower grade tumors by necrosis and microvascular …
distinguished pathologically from lower grade tumors by necrosis and microvascular …
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
X Xia, ME Lemieux, W Li, JS Carroll… - Proceedings of the …, 2009 - National Acad Sciences
Adaptation to hypoxia is mediated through a coordinated transcriptional response driven
largely by hypoxia-inducible factor 1 (HIF-1). We used ChIP-chip and gene expression …
largely by hypoxia-inducible factor 1 (HIF-1). We used ChIP-chip and gene expression …
Aberrant signaling pathways in glioma
M Nakada, D Kita, T Watanabe, Y Hayashi, L Teng… - Cancers, 2011 - mdpi.com
Glioblastoma multiforme (GBM), a WHO grade IV malignant glioma, is the most common and
lethal primary brain tumor in adults; few treatments are available. Median survival rates …
lethal primary brain tumor in adults; few treatments are available. Median survival rates …
Angiogenesis and invasion in glioma
M Onishi, T Ichikawa, K Kurozumi, I Date - Brain tumor pathology, 2011 - Springer
Despite advances in surgical and medical therapy, glioblastoma consistently remains a fatal
disease. Over the last 20 years, no significant increase in survival has been achieved for …
disease. Over the last 20 years, no significant increase in survival has been achieved for …
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
RL Jensen - Journal of neuro-oncology, 2009 - Springer
Hypoxia is implicated in many aspects of tumor development, angiogenesis, and growth in
many different tumors. Brain tumors, particularly the highly aggressive glioblastoma …
many different tumors. Brain tumors, particularly the highly aggressive glioblastoma …
Hypoxia is important in the biology and aggression of human glial brain tumors
SM Evans, KD Judy, I Dunphy, WT Jenkins… - Clinical Cancer …, 2004 - AACR
We investigated whether increasing levels of tissue hypoxia, measured by the binding of
EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2, 2, 3, 3, 3-pentafluoropropyl) acetamide] or by …
EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2, 2, 3, 3, 3-pentafluoropropyl) acetamide] or by …